Components of the revised International Prognostic Scoring System and outcome after hematopoietic cell transplantation for myelodysplastic syndrome

被引：4
|
作者：
Gerds, Aaron T. [1 ]
Gooley, Ted A. [1 ]
Wilson, Wendy A. [2 ]
Deeg, H. Joachim [1 ]
机构：
[1] Univ Washington, Med Ctr, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
来源：
BLOOD | 2013年 / 121卷 / 19期
关键词：
LEUKEMIA; MUTATIONS; MDS;
D O I：
10.1182/blood-2013-02-486118
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4007 / 4008
页数：2
相关论文
共 50 条
  • [41] Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System
    Jung, Ki Sun
    Kim, Yoo-Jin
    Kim, Yeo-Kyeoung
    Park, Sung Kyu
    Kim, Hoon Gu
    Kim, Soo Jeong
    Park, Jinny
    Choi, Chul Won
    Do, Young Rok
    Kim, Inho
    Park, Seonyang
    Mun, Yeung-Chul
    Jeong, Seong Hyun
    Kim, Min-Kyoung
    Yi, Hyeon Gyu
    Chang, Myung Hee
    Kim, Su Youn
    Lee, Je-Hwan
    Jang, Jun Ho
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10) : 656 - 664
  • [42] Hematopoietic Cell Transplantation in Myelodysplastic Syndromes after Treatment with Hypomethylating Agents
    Festuccia, Moreno
    Baker, Kelsey
    Gooley, Theodore A.
    Sandmaier, Brenda M.
    Deeg, H. Joachim
    Scott, Bart L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1509 - 1514
  • [43] Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification
    Lee, Wan-Hsuan
    Tsai, Ming-Tao
    Tsai, Cheng-Hong
    Tien, Feng-Ming
    Lo, Min-Yen
    Tseng, Mei-Hsuan
    Kuo, Yuan-Yeh
    Liu, Ming-Chih
    Yang, Yi-Tsung
    Chen, Jui-Che
    Tang, Jih-Luh
    Sun, Hsun-, I
    Chuang, Yi-Kuang
    Lin, Liang-In
    Chou, Wen-Chien
    Lin, Chien-Chin
    Hou, Hsin-An
    Tien, Hwei-Fang
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [44] Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
    Sauta, Elisabetta
    Robin, Marie
    Bersanelli, Matteo
    Travaglino, Erica
    Meggendorfer, Manja
    Zhao, Lin-Pierre
    Caballero Berrocal, Juan Carlos
    Sala, Claudia
    Maggioni, Giulia
    Bernardi, Massimo
    Di Grazia, Carmen
    Vago, Luca
    Rivoli, Giulia
    Borin, Lorenza
    D'Amico, Saverio
    Tentori, Cristina Astrid
    Ubezio, Marta
    Campagna, Alessia
    Russo, Antonio
    Mannina, Daniele
    Lanino, Luca
    Chiusolo, Patrizia
    Giaccone, Luisa
    Voso, Maria Teresa
    Riva, Marta
    Oliva, Esther Natalie
    Zampini, Matteo
    Riva, Elena
    Nibourel, Olivier
    Bicchieri, Marilena
    Bolli, Niccolo'
    Rambaldi, Alessandro
    Passamonti, Francesco
    Savevski, Victor
    Santoro, Armando
    Germing, Ulrich
    Kordasti, Shahram
    Santini, Valeria
    Diez-Campelo, Maria
    Sanz, Guillermo
    Sole, Francesc
    Kern, Wolfgang
    Platzbecker, Uwe
    Ades, Lionel
    Fenaux, Pierre
    Haferlach, Torsten
    Castellani, Gastone
    Della Porta, Matteo Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (15) : 2827 - +
  • [45] Validation and improvement of the molecular international prognostic scoring system in Chinese patients with myelodysplastic syndromes
    Huang, Nanfang
    Song, Yang
    Wu, Lingyun
    He, Qi
    Zhang, Zheng
    Guo, Juan
    Xu, Feng
    Chang, Chunkang
    Li, Xiao
    ANNALS OF HEMATOLOGY, 2025, 104 (01) : 193 - 206
  • [46] Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis
    Abboud, Ramzi
    Wan, Fei
    Mariotti, Jacopo
    Arango, Marcos
    Castagna, Luca
    Romee, Rizwan
    Hamadani, Mehdi
    Chhabra, Saurabh
    BONE MARROW TRANSPLANTATION, 2021, 56 (11) : 2763 - 2770
  • [47] Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic Syndrome
    Festuccia, Moreno
    Deeg, H. Joachim
    Gooley, Theodore A.
    Baker, Kelsey
    Wood, Brent L.
    Fang, Min
    Sandmaier, Brenda M.
    Scott, Bart L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (07) : 1227 - 1233
  • [48] Reply to 'Allogeneic hematopoietic cell transplantation for concurrent multiple myeloma and myelodysplastic syndrome'
    Schroeder, T.
    Fenk, R.
    Haas, R.
    Germing, U.
    Kobbe, G.
    BONE MARROW TRANSPLANTATION, 2015, 50 (11) : 1483 - 1485
  • [49] Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation
    Wachter, Franziska
    Pikman, Yana
    Bledsoe, Jacob
    Kapadia, Malika
    Baumeister, Susanne
    Rowe, Jared
    Shimamura, Akiko
    Place, Andrew E.
    Prockop, Susan
    Whangbo, Jennifer
    Lehmann, Leslie
    Horan, John
    Pollard, Jessica
    CLINICAL CASE REPORTS, 2023, 11 (11):
  • [50] Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies
    T-C Huang
    B-S Ko
    J-L Tang
    C Hsu
    C-Y Chen
    W Tsay
    S-Y Huang
    M Yao
    Y-C Chen
    M-C Shen
    C-H Wang
    H-F Tien
    Leukemia, 2008, 22 : 544 - 550
12345